Zenas.
Person
- Reports this week
- 0
- Active events
- 0
- Connections
- 17
What's happening
Earlier this month
-
Zenas presented data in Cambridge, Massachusetts on October 12, 2026.Some support1 report
-
Zenas has announced a new research focus targeting diseases that are studied by the Lupus Foundation of America.Some support1 report
-
Zenvia Inc. utilized the LinkedIn platform for its social media presence.Some support4 reports
One to three months ago
Gone quiet
No new reports in 90+ daysNo events began in the chosen period. Widen it, or reset.
Around Zenas this week
News at the entities that move Zenas most-
FDA TransactionalNeurogene Inc. developed a gene therapy for Rett syndrome and received FDA agreement for a registrational trial design.Moves Zenas
-
Royalty Pharma TransactionalRoyalty Pharma and Aditxt, two healthcare companies, are currently being compared.Moves Zenas
-
United Therapeutics OperationalVarious financial institutions, including Royal Bank of Canada, Bank of America, Raymond James Financial, TD Cowen, Cantor Fitzgerald, and MarketBeat, issued rating and price target updates regarding United Therapeutics on July 10, 2026.Moves Zenas
-
Nasdaq StructuralA Vertex employee won an Info-Tech award, the company is listed on Nasdaq, and Sarah Vlasic leads Leadership Circles at the University of Colorado Boulder.Moves Zenas
-
LinkedIn Mentioned togetherA dispute arose over false and defamatory advertisements involving a son's LinkedIn profile, operating under Pennsylvania state law.Moves Zenas
-
Cambridge Shared contextCambridge is attracting talent and innovation, with AI and tech companies driving demand for office space.Moves Zenas
Connections
The 11 strongest of 17, analyzed from the reporting. The bars show how strongly a change on one side reaches the other.-
Royalty Pharma Transactional
Royalty Pharma provided funding to Zenas in exchange for a royalty on sales.
-
Nasdaq Structural
Zenas operates as a listed entity on the Nasdaq stock exchange.
-
FDA Transactional
The FDA formally accepted Zenas's Biologics License Application, granting it market access.
-
United Therapeutics Operational
The evidence suggests both entities are healthcare companies actively competing for market share.
-
Relay Therapeutics Operational
The evidence suggests both entities operate in the mid-cap healthcare sector and are in competition.
-
LinkedIn Mentioned together
Zenas utilizes LinkedIn as a platform to access company and investor relations information.
-
Waltham Shared context
Zenas operates from a headquarters situated in Waltham, Massachusetts.
-
Lupus Foundation of America Operational
Zenas targets diseases that are studied by the Lupus Foundation of America.
Show all 11 connections
-
Arcturus Therapeutics Operational
Both entities are healthcare companies actively competing for investment opportunities.
-
Cambridge Shared context
Zenas performed a presentation in Cambridge, Massachusetts.
-
Bristol-Myers Squibb Mentioned together
No evidence was provided in the timeline to establish a relationship between Bristol-Myers Squibb and Zenas.